Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms
Abstract
Abstract SARS-CoV-2 infection affects multiple immune mechanisms and leads to severe COVID-19 and death, in part related to infection-induced or pre-existing autoantibodies. Here, we describe severe COVID-19 to associate with autoantibodies against interleukin-1 receptor antagonist (IL-1Ra) and progranulin (PGRN), endogenous antagonists of IL-1 and TNF signaling, respectively. These autoantibodies coincide with hyperphosphorylation of IL-1Ra (Thr111) or PGRN (Ser81), form immune complexes independent of phosphorylation, reduce antigen plasma levels, and permit enhanced IL-1 and TNF signaling. Using phage-display selected Fabs specific for hyperphosphorylated isoforms, we track phospho-antigens and autoantibodies in a German national pandemic network cohort. Most seropositive patients show both autoantibodies. Levels peak at baseline and decline over 12 months, with phospho-antigens decreasing before autoantibodies. Seropositivity associates with hyperinflammation and cytokine profiles. Importantly, signaling by key inflammatory cytokines induce IL-1Ra and PGRN hyperphosphorylation in healthy monocytes, but require up to 1000-fold higher doses than in monocytes from previously seropositive severe COVID-19 survivors.
Article Details
Authors (82)
Lorenz Thurner
Natalie Fadle
Bernhard Thurner
Igor Age Kos
Moritz Bewarder
Evi Regitz
Birgit Bette
Yvan Fischer
Vadim Lesan
Torben Rixecker
Marie-Christin Hoffmann
Klaus-Dieter Preuss
Claudia Schormann
Dominic Kaddu-Mulindwa
Klaus Roemer
Onur Cetin
Sebastian Mang
André Becker
Frederik Seiler
Christian Herr
Christian Lensch
Johannes Lehmann
Angela Thiel-Bodenstaff
Andreas Link
Christian Werner
Biocenter, Department of Biotechnology and Biophysics, Julius-Maximilians-Universität (JMU) Würzburg, Am Hubland, 97074 Würzburg, Germany
Patrick Wuchter
Sixten Körper
Thorsten Pfuhl
Stefan Lohse
Jürgen Rissland
Katrin Thieser
Jan Pilch
Cihan Papan
Sophie Roth
J. Janne Vehreschild
Margarete Scherer
Isabel Bröhl
Patricia Wagner
Martin Witzenrath
Charlotte Thibeault
Ira an Haack
Lazar Mitrov
Sina M. Pütz
Jens-Peter Reese
Michael Krawczak
Eckard Hamelmann
Verena Kopfnagel
Karin Fiedler
Ramsia Geisler
Heike Valentin
Dana Stahl
Sabine Hanß
Sabine Ameling
Department of Functional Genomics, Universitätsmedizin Greifswald, Greifswald, Germany
Uwe Völker
Department of Functional Genomics, Universitätsmedizin Greifswald, Greifswald, Germany
Stefan Hansch
Marcus Dörr
Sabine Blaschke
Josephine Braunsteiner
Edgar Dahl
Daniel Pape
Astrid Petersmann
Stephan Stilgenbauer
Division of CLL, Department of Internal Medicine III, Ulm University, Ulm, Germany
Frank Bloos
Hubert Schrezenmeier
Frank Langer
Gereon Gäbelein
Bettina Friesenhahn-Ochs
Jochen Pfeifer
Michael Bauer
Sören Leif Becker
Frank Neumann
Michael Böhm
Gabriele Anton
Carsten Kuenne
Soni Savai Pullamsetti
Mario Looso
Robert Bals
Sigrun Smola
Patrick Meybohm
Marcin Krawczyk
Philipp M. Lepper
Christoph Kessel